State Of Wisconsin Investment Board Voyager Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.61 - $9.04 $153,052 - $300,128	-33,200 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$7.15 - $12.28 $29,315 - $50,348	-4,100 Reduced 10.99%	33,200 $237,000
Q3 2020 Nov 16, 2020	SELL	$10.01 - $13.75 $28,028 - $38,500	-2,800 Reduced 6.98%	37,300 $398,000
Q2 2020 Aug 12, 2020	SELL	$8.05 - $14.21 $11,270 - $19,894	-1,400 Reduced 3.37%	40,100 $506,000
Q1 2020 May 06, 2020	BUY	$6.8 - $14.66 $36,040 - $77,698	5,300 Added 14.64%	41,500 $380,000
Q3 2019 Nov 12, 2019	BUY	$16.31 - $28.29 $104,383 - $181,056	6,400 Added 21.48%	36,200 $623,000
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $13,426 - $19,516	700 Added 2.41%	29,800 $811,000
Q1 2019 May 13, 2019	BUY	$8.0 - $19.66 $52,800 - $129,756	6,600 Added 29.33%	29,100 $557,000
Q3 2018 Nov 14, 2018	BUY	$17.11 - $21.74 $213,875 - $271,750	12,500 Added 125.0%	22,500 $426,000
Q3 2017 Nov 01, 2017	BUY	$8.37 - $20.59 $83,699 - $205,900	10,000	10,000 $206,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $207M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.